Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic vs original rosuvastatin + ezetimibe for LDL-C reduction
TCTR20260920003Phase 4Not yet recruiting
- Sponsor
- Berlin Pharmaceutical
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, ezetimibe in hypercholesterolemia, sponsored by Berlin Pharmaceutical. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20260920003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260920003.